動物用感染症診断薬市場：技術別、動物タイプ別、感染タイプ別、エンドユーザー別-2025-2030年世界予測

動物用感染症診断薬市場は、2023年に21億7,000万米ドルと評価され、2024年には23億9,000万米ドルに達すると予測され、CAGR 10.39％で成長し、2030年には43億5,000万米ドルになると予測されています。

動物用感染症診断薬市場には、動物の病原体や病気を検出するために設計されたさまざまな検査やツールが含まれます。この市場は、動物の健康を守り、人獣共通感染症を予防して公衆衛生を支え、家畜の生産性を確保するために不可欠です。主な診断方法には、血清学的検査、分子診断（PCRなど）、ポイントオブケア検査などがあります。主な用途には、動物病院、研究機関、診断研究所における疾病モニタリング、発生管理、日常的な健康診断が含まれます。最終用途の範囲はコンパニオンアニマル、家畜、野生動物であり、家畜診断は経済と食糧安全保障上の理由から重要です。市場成長は、ペット飼育数の増加、家畜個体数の増加、診断技術の進歩、動物の健康と食の安全への関心の高まりに大きく影響されています。資源に乏しい環境における費用対効果の高い迅速なポイントオブケア診断法の開発や、疾病監視・管理の改善のためのデータ統合の強化には多くの機会があります。データ主導のソリューションを革新するための技術企業と獣医療機関のコラボレーションも大きな可能性を秘めています。しかし、主な課題としては、高度な診断ツールの高コスト、標準化の欠如、規制上のハードル、発展途上地域における認知度の低さなどが挙げられます。また、既存の検査が時代遅れになりかねない病原体の急速な変異や、複雑なデータを解釈するための教育された専門家の必要性にも取り組んでいます。イノベーションは、1回の検査で複数の病原体の包括的なプロファイルを提供するマルチプレックス検査機能、予測診断のためのAI主導型データ分析、農村部や遠隔地向けのモバイル診断技術に焦点を当てることができます。同市場は、技術統合と分野横断的な協力に傾斜したダイナミックな性質を示し、成長への有望な、しかし課題的な背景を反映しています。市場機会を生かすため、利害関係者は堅牢なデータ分析サービスを備えた、アクセスしやすく手頃な価格のソリューションの開発に注力し、動物用診断薬のイノベーションと標準化を支援する政策枠組みを提唱すべきです。

市場力学：急速に進化する動物用感染症診断薬市場の主要市場インサイトを公開

動物用感染症診断薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • コンパニオンアニマル人口とペットケア支出の増加
  • 動物疾病の流行と獣医開業医の増加
  • 食肉と牛乳の消費の増加と獣医療に対する政府の支援
• 市場抑制要因
  • 動物用感染症診断薬の高コスト
• 市場機会
  • 世界のペット保険サービスの向上
  • 動物用感染症診断薬の研究開発
• 市場の課題
  • 熟練した専門家の不足

ポーターの5つの力：動物用感染症診断薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、動物用感染症診断薬市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：動物用感染症診断薬市場における外部からの影響の把握

外部マクロ環境要因は、動物用感染症診断薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析動物用感染症診断薬市場における競合情勢の把握

動物用感染症診断薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス動物用感染症診断薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、動物用感染症診断薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨動物用感染症診断薬市場における成功への道筋を描く

動物用感染症診断薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ペットの人口とペットケア支出の増加
    • 動物の病気の蔓延と獣医師数の増加
    • 肉と牛乳の消費量の増加と獣医医療に対する政府の支援
  • 抑制要因
    • 動物用感染症診断薬のコストが高い
  • 機会
    • 世界中でペット保険サービスの向上
    • 動物用感染症診断薬における調査開発
  • 課題
    • 熟練した専門家の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 動物用感染症診断薬市場：技術別

• ELISA検査
• 免疫診断
• ラテラルフローアッセイ
• マイクロアレイ
• 分子診断
• ポリメラーゼ連鎖反応（PCR）検査

第7章 動物用感染症診断薬市場動物の種類別

• 猫
• 犬
• 馬

第8章 動物用感染症診断薬市場感染タイプ別

• 細菌感染症
• 寄生虫感染症
• ウイルス感染

第9章 動物用感染症診断薬市場：エンドユーザー別

• ポイントオブケア/社内検査
• リファレンスラボ
• 調査機関および大学
• 動物病院・クリニック

第10章 南北アメリカの動物用感染症診断薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の動物用感染症診断薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの動物用感染症診断薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agrolabo S.p.A.
• Biogal Galed Labs
• BioMerieux S.A.
• BioNote, Inc.
• Fassisi GmbH
• FUJIFILM Holdings Corporation
• Heska Corporation
• IDEXX Laboratories, Inc.
• IDvet
• Neogen Corporation
• Precision Biosensor Inc.
• Randox Laboratories, Ltd.
• Shenzhen Bioeasy Biotechnology Co., Ltd.
• Shenzhen Mindray Animal Medical Technology Co., Ltd.
• SKYER, Inc.
• Skyla Corporation
• Thermo Fisher Scientific Inc.
• Vimian Group AB
• Virbac S.A.
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH PROCESS
• FIGURE 2. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET DYNAMICS
• TABLE 7. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR) TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HORSES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE/ IN-HOUSE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES & UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 41. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 42. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 43. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 63. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 64. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 65. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 68. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 69. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. ITALY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. ITALY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 137. ITALY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 138. ITALY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 151. POLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 152. POLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 153. POLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 154. POLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 155. QATAR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 156. QATAR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 157. QATAR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 158. QATAR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 195. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 196. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Veterinary Infectious Disease Diagnostics Market was valued at USD 2.17 billion in 2023, expected to reach USD 2.39 billion in 2024, and is projected to grow at a CAGR of 10.39%, to USD 4.35 billion by 2030.

The veterinary infectious disease diagnostics market encompasses a range of tests and tools designed to detect pathogens and diseases in animals. This market is essential for safeguarding animal health, supporting public health by preventing zoonotic diseases, and ensuring livestock productivity. Key diagnostic methods include serological tests, molecular diagnostics (such as PCR), and point-of-care tests. The primary applications include disease monitoring, outbreak control, and routine health checks across veterinary clinics, research institutions, and diagnostic laboratories. The end-use scope covers companion animals, livestock, and wildlife, with livestock diagnostics being critical for economic and food security reasons. Market growth is significantly influenced by rising pet ownership, increasing livestock populations, advancements in diagnostic technologies, and a heightened focus on animal health and food safety. Opportunities abound in developing cost-effective, rapid point-of-care diagnostics for resource-limited settings and in enhancing data integration for improved disease surveillance and management. Collaborations between tech companies and veterinary organizations to innovate data-driven solutions also present substantial potential. However, key challenges include the high cost of advanced diagnostic tools, lack of standardization, regulatory hurdles, and limited awareness in developing regions. The market also grapples with the fast mutation of pathogens, which can render existing tests obsolete, and the need for educated professionals to interpret complex data. Innovations could focus on multiplex testing capabilities that provide comprehensive profiles of multiple pathogens in a single test, AI-driven data analytics for predictive diagnostics, and mobile diagnostic tech for rural and remote areas. The market exhibits a dynamic nature inclined towards technological integration and cross-sector collaboration, reflecting a promising yet challenging backdrop for growth. To capitalize on market opportunities, stakeholders should focus on creating accessible, affordable solutions with robust data analysis services, and advocate for policy frameworks that support innovation and standardization in veterinary diagnostics.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Infectious Disease Diagnostics Market

The Veterinary Infectious Disease Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing companion animal population and pet care expenditure
  • Prevalence of animal disease and increasing number of veterinary practitioners
  • Increasing consumption of meat & milk and government support for veterinary care
• Market Restraints
  • High cost of veterinary infectious disease diagnostics
• Market Opportunities
  • Improving pet insurance services worldwide
  • Research and developments in veterinary infectious disease diagnostics
• Market Challenges
  • Dearth of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Infectious Disease Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Infectious Disease Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Infectious Disease Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Infectious Disease Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Infectious Disease Diagnostics Market

A detailed market share analysis in the Veterinary Infectious Disease Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Infectious Disease Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Infectious Disease Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Infectious Disease Diagnostics Market

A strategic analysis of the Veterinary Infectious Disease Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Infectious Disease Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Agrolabo S.p.A., Biogal Galed Labs, BioMerieux S.A., BioNote, Inc., Fassisi GmbH, FUJIFILM Holdings Corporation, Heska Corporation, IDEXX Laboratories, Inc., IDvet, Neogen Corporation, Precision Biosensor Inc., Randox Laboratories, Ltd., Shenzhen Bioeasy Biotechnology Co., Ltd., Shenzhen Mindray Animal Medical Technology Co., Ltd., SKYER, Inc., Skyla Corporation, Thermo Fisher Scientific Inc., Vimian Group AB, Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Infectious Disease Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across ELISA Test, Immunodiagnostics, Lateral Flow Assays, Microarrays, Molecular Diagnostic, and Polymerase Chain Reaction (PCR) Tests.
• Based on Animal Type, market is studied across Cats, Dogs, and Horses.
• Based on Infection Type, market is studied across Bacterial Infections, Parasitic Infections, and Viral Infections.
• Based on End User, market is studied across Point-of-Care/ In-House Testing, Reference Laboratories, Research Institutes & Universities, and Veterinary Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing companion animal population and pet care expenditure
    • 5.1.1.2. Prevalence of animal disease and increasing number of veterinary practitioners
    • 5.1.1.3. Increasing consumption of meat & milk and government support for veterinary care
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of veterinary infectious disease diagnostics
  • 5.1.3. Opportunities
    • 5.1.3.1. Improving pet insurance services worldwide
    • 5.1.3.2. Research and developments in veterinary infectious disease diagnostics
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of skilled professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Veterinary Infectious Disease Diagnostics Market, by Technology

• 6.1. Introduction
• 6.2. ELISA Test
• 6.3. Immunodiagnostics
• 6.4. Lateral Flow Assays
• 6.5. Microarrays
• 6.6. Molecular Diagnostic
• 6.7. Polymerase Chain Reaction (PCR) Tests

7. Veterinary Infectious Disease Diagnostics Market, by Animal Type

• 7.1. Introduction
• 7.2. Cats
• 7.3. Dogs
• 7.4. Horses

8. Veterinary Infectious Disease Diagnostics Market, by Infection Type

• 8.1. Introduction
• 8.2. Bacterial Infections
• 8.3. Parasitic Infections
• 8.4. Viral Infections

9. Veterinary Infectious Disease Diagnostics Market, by End User

• 9.1. Introduction
• 9.2. Point-of-Care/ In-House Testing
• 9.3. Reference Laboratories
• 9.4. Research Institutes & Universities
• 9.5. Veterinary Hospitals & Clinics

10. Americas Veterinary Infectious Disease Diagnostics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Veterinary Infectious Disease Diagnostics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Veterinary Infectious Disease Diagnostics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agrolabo S.p.A.
• 2. Biogal Galed Labs
• 3. BioMerieux S.A.
• 4. BioNote, Inc.
• 5. Fassisi GmbH
• 6. FUJIFILM Holdings Corporation
• 7. Heska Corporation
• 8. IDEXX Laboratories, Inc.
• 9. IDvet
• 10. Neogen Corporation
• 11. Precision Biosensor Inc.
• 12. Randox Laboratories, Ltd.
• 13. Shenzhen Bioeasy Biotechnology Co., Ltd.
• 14. Shenzhen Mindray Animal Medical Technology Co., Ltd.
• 15. SKYER, Inc.
• 16. Skyla Corporation
• 17. Thermo Fisher Scientific Inc.
• 18. Vimian Group AB
• 19. Virbac S.A.
• 20. Zoetis Inc.